BioSpace News Archive

Drug Development

Elevar Touts First-line Potential of Rivoceranib in Phase III Liver Cancer Trial

Late-stage data, which showed significant overall and progression-free survival benefits in unresectable hepatocellular carcinoma patients, supports Elevar’s New Drug Application filed in May 2023.

July 25, 2023
·
2 min read
·
Tristan Manalac
Business

Biogen to Cut 1,000 Jobs as Part of $1B Cost Savings Plan

The biotech’s “Fit for Growth” program, which includes the headcount reduction, is expected to generate a net savings of $700 million on operating expenses by 2025.

July 25, 2023
·
3 min read
·
Kate Goodwin
Business

Alvotech Expands Biosimilar Collaboration with Teva Amid Manufacturing Woes

Following two BLA rejections for its Humira biosimilar, Alvotech is expanding its partnership with Teva Pharmaceuticals, which will enable the latter to have greater involvement with quality and control.

July 25, 2023
·
2 min read
·
Tristan Manalac
From Crisis to Cure: Unraveling the Cancer Drug Shortage and the FDA’s Role

While chemo drugs remain in shortage, Congress asks for answers from the FDA to find solutions to the supply chain disintegration.

July 25, 2023
·
4 min read
·
Lisa Munger
Business

Roche Decides Not to Exercise Solid Tumor Option with SQZ

Embattled SQZ Biotechnologies announced Tuesday that the Swiss biotech will not exercise its option for HPV 16 positive solid tumors under the SQZ-APC-HPV program.

July 25, 2023
·
2 min read
·
Connor Lynch
Business

ImmunoGen Inks Cancer ADC Partnership with ImmunoBiochem

The license and option deal, for an undisclosed amount, seeks to develop potentially first-in-class antibody-drug conjugate candidates against different oncology targets.

July 25, 2023
·
2 min read
·
Tristan Manalac
Biotech Bay

Iovance Biotherapeutics to Present Clinical Data for Tumor Infiltrating Lymphocyte (TIL) Therapy at IASLC 2023 World Conference on Lung Cancer

Iovance Biotherapeutics, Inc. announced oral and poster presentations reporting clinical and preclinical data for tumor infiltrating lymphocyte therapies at IASLC 2023 World Conference on Lung Cancer hosted by the International Association for the Study of Lung Cancer in Singapore, September 9-12, 2023.

July 25, 2023
·
6 min read
Bio NC

RedHill Biopharma Announces Closing of $3.8 Million Registered Direct Offering and Warrant Exercise

RedHill Biopharma Ltd. announced that it has closed its previously announced registered direct offering for the purchase and sale of 1,301,923 of the Company’s American Depositary Shares, each ADS representing four hundred ordinary shares, at a purchase price of $1.35 per ADS.

July 25, 2023
·
10 min read
Business

Personalis to Announce Second Quarter 2023 Financial Results

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that it will release its second quarter 2023 financial results on Tuesday, August 8, 2023.

July 25, 2023
·
1 min read
Policy

FDA Roundup: July 25, 2023

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

July 25, 2023
·
3 min read